VELOX MCS (microcrystalline starch) is a proprietary new excipient for the preparation of pharmaceutical pellets that enable rapid and complete release of poorly soluble drugs. VELOX MCS disintegrates rapidly in the gastrointestinal tract in contrast to microcrystalline cellulose.
VELOX MCS has the requisite physical properties to produce smooth, uniform spheres via the extrusion-spheronization process. The spheres can be produced in high yield with low friability and are suitable for enteric coating. VELOX MCS meets the specifications in the Food Chemicals Codex and the FDA requirements for maltodextrin under 21 CFR 184.1444.